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Background
HIV-1 CRF07_B'C recombinant previously circulated
mainly among the intravenous drug users (IDUs) in
Northwest China and is currently spreading in the entire
country. The aim of this study is to characterize the geno-
typic, phenotypic properties as well as neutralization pro-
file of virus strains in comparison with the subtype B'
(Thailand B) which is prevalent in the former plasma
donors (FPDs) in centre China.
Methods
12 CRF07_BC and 20 subtype B' HIV-1 strains were iso-
lated from Xinjiang and Anhui. Replication kinetics of the
generated virus stock was performed every 2–3 days in
PHA-stimulated PBMCs. HIV-1 Co-receptor usage was
detected using Ghost cells, and a sensitive HIV-1 neutrali-
zation assay based on TZM-b1 cells was performed to
detect the neutralization activity of plasma from patients
infected with autologous and heterologous viruses.
Results
12 CRF07_B'C viruses utilized CCR5 co-receptor, while
they had lower net charge value in the V3 loop and exhib-
ited slower replication kinetics than subtype B' viruses.
The number and location of the potential N-linked glyco-
sylation sites in V1/V2 and the C2 region of the
CRF07_B'C viruses were significantly different from those
of the subtype B' viruses. The plasmas from patients
infected with CRF07_B'C virus effectively neutralized
more than fifty percent of heterologous viruses but failed
to neutralize autologous HIV-1. The neutralizing activity
of their plasmas was negatively corrected with neutraliza-
tion sensitivity of HIV-1 isolates from the patents. Ten per-
cent of the plasmas with potent neutralizing activity
against autologous viurses were also effective in neutraliz-
ing infection by HIV-1 subtypes besides B' and B'/C.
Conclusion
This study suggests that CRF07_B'C may be superior over
B' in stimulating cross clade neutralizing antibody. It also
indicates that some of these HIV-1 viruses can elicit both
intragroup and cross-clade neutralizing antibodies.
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